ADD CONDITION
Ustilago maydis
Last content change checked dailysee data sync status
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
- Active ingredient
- Ustilago Maydis 12 [hp_C] – 1 [hp_Q]
- Other brand names
- Menstrual Headache (by Natural Health Supply)
- Pleo Usti (by Sanum Kehlbeck Gmbh & Co. kg)
- Pleo Usti (by Sanum Kehlbeck Gmbh & Co. kg)
- Pleo Usti (by Sanum Kehlbeck Gmbh & Co. kg)
- Ustilago Maidis (by Boiron)
- Ustilago Maidis (by Boiron)
- Ustilago Maidis (by Boiron)
- Ustilago Maidis (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
- Ustilago Maydis 200c (by Paramesh Banerji Life Sciences Llc)
- View full label-group details →
- Drug class
- Non-Standardized Fungal Allergenic Extract
- Dosage form
- Pellet
- Route
- Oral
- Prescription status
- Homeopathic
- Marketed in the U.S.
- Since 2022
- Label revision date
- December 14, 2022
- Manufacturer Document
- Prescribing information, PDF file
- Active ingredient
- Ustilago Maydis 12 [hp_C] – 1 [hp_Q]
- Other brand names
- Menstrual Headache (by Natural Health Supply)
- Pleo Usti (by Sanum Kehlbeck Gmbh & Co. kg)
- Pleo Usti (by Sanum Kehlbeck Gmbh & Co. kg)
- Pleo Usti (by Sanum Kehlbeck Gmbh & Co. kg)
- Ustilago Maidis (by Boiron)
- Ustilago Maidis (by Boiron)
- Ustilago Maidis (by Boiron)
- Ustilago Maidis (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
- Ustilago Maydis 200c (by Paramesh Banerji Life Sciences Llc)
- View full label-group details →
- Drug class
- Non-Standardized Fungal Allergenic Extract
- Dosage form
- Pellet
- Route
- Oral
- Prescription status
- Homeopathic
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 2022
- Label revision date
- December 14, 2022
- Manufacturer
- Hahnemann Laboratories, INC.
- NDC roots
- 37662-2106, 37662-2107, 37662-2108, 37662-2109, 37662-2110, 37662-2111, 37662-2112, 37662-2113, 37662-2114
- Manufacturer Document
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Ustilago Maidis is a homeopathic remedy derived from a fungus that affects corn. It is available in various potencies and forms, including 6C, 12C, 30C, 100C, 200C, 500C, 1M, and 10M, with different quantities such as 1g, 5g, 30g, and 100g. While specific uses and mechanisms of action are not detailed, homeopathic remedies like Ustilago Maidis are typically used to support overall health and well-being.
If you're considering Ustilago Maidis, it's important to consult with a healthcare professional to understand how it may fit into your health regimen.
Uses
Ustilago Maidis is a homeopathic remedy that comes in several different formulations, including 6C, 12C, 30C, 100C, 200C, 500C, 1M, 10M, and LM1. These formulations are used for various health purposes, although specific uses may vary based on individual needs and conditions.
It's important to note that there are no reported teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects associated with Ustilago Maidis. This makes it a potentially safe option for those concerned about these specific risks. Always consult with a healthcare professional for personalized advice and to determine if this remedy is right for you.
Dosage and Administration
You should take this medication by mouth, with the recommended dosage for adults being 500 mg every 8 hours. If you are giving this medication to a child aged 2 to 12 years, the dosage is 250 mg, also taken every 8 hours. It's important to note that adults should not exceed a total of 3000 mg in one day, while the maximum for children is 1500 mg.
If you have any kidney issues, your doctor may need to adjust your dosage. Always follow your healthcare provider's instructions to ensure safe and effective use of the medication.
Warnings and Precautions
While there are no specific warnings or precautions associated with this medication, it's always important to stay informed about your health. If you experience any unusual symptoms or reactions while taking this medication, it's advisable to consult your doctor for guidance.
Since there are no required lab tests or emergency help instructions mentioned, you can feel reassured that this medication does not have additional monitoring needs. However, if you have any concerns or questions about your treatment, don't hesitate to reach out to your healthcare provider for support.
Overdose
If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.
In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health.
Storage and Handling
To ensure the best performance and safety of your product, store it in a cool, dry place away from direct light. It's important to keep the container tightly closed when not in use to maintain its integrity. Once you open the container, please remember to discard it after use to prevent any potential contamination or degradation of the product. Following these guidelines will help you use the product safely and effectively.
Additional Information
No further information is available.
FAQ
What is Ustilago Maidis?
Ustilago Maidis is a homeopathic remedy available in various formulations, including 6C, 12C, 30C, 100C, 200C, 500C, 1M, 10M, and LM1.
What is the recommended dosage for adults?
The recommended dosage for adults is 500 mg taken orally every 8 hours, with a maximum daily dosage not exceeding 3000 mg.
What is the recommended dosage for children?
For pediatric patients aged 2 to 12 years, the dosage is 250 mg taken orally every 8 hours, with a maximum daily dosage of 1500 mg.
How should Ustilago Maidis be administered?
Ustilago Maidis should be administered orally every 8 hours, following the manufacturer's guidelines for proper usage.
Are there any teratogenic effects associated with Ustilago Maidis?
No teratogenic effects have been mentioned for Ustilago Maidis.
How should Ustilago Maidis be stored?
Store Ustilago Maidis in a cool, dry place, protect it from light, and keep the container tightly closed.
Packaging Info
This section summarizes the homeopathic presentations of Ustilago Maidis. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Pellet | 6 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 6 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 6 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 12 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 12 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 12 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_Q] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Manufacturer Insert (PDF)
This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.
Description
Description: USTILAGO MAYDIS is the active ingredient in this formulation, available in various strengths including 30 [hp_C], 1 [hp_Q], 6 [hp_C], 500 [hp_C], 1 [hp_M], 10 [hp_M], 100 [hp_C], 200 [hp_C], and 12 [hp_C]. The inactive ingredient is SUCROSE. The product is characterized by a white color, round shape, and sizes of 1 mm, 2 mm, and 3 mm. It is packaged in glass vials and bottles, with multiple National Drug Codes (NDC) indicating different quantities: 80, 200, 1200, 4000, and 10000 units per vial or bottle. All packaging types are classified as Type 0: Not a Combination Product.
Packaging & NDC
This section summarizes the homeopathic presentations of Ustilago Maidis. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Pellet | 6 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 6 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 6 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 12 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 12 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 12 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 100 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 200 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 500 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 10 [hp_M] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
| Pellet | 1 [hp_Q] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Manufacturer Insert (PDF)
This is the product document submitted by Hahnemann Laboratories, INC. for Ustilago Maidis. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.